Exploring the use of niosomes in cosmetics for efficient dermal drug delivery

References

• Abd-Elbary A, El-Laithy HM, Tadros MI. 2008. Sucrose stearate-based proniosome-derived niosomes for the nebulisable delivery of cromolyn sodium. Int J Pharm. 357(1–2):189–198. doi: 10.1016/j.ijpharm.2008.01.056.
   PubMed Web of Science ®Google Scholar
• Abu-Huwaij R, Al-Assaf S, Mousli F, Kutkut M, Al-Bashtawi A. 2020. Perceptive review on properties of iron oxide nanoparticles and their antimicrobial and anticancer activity. Sys Rev Pharm. 11(8):418–431.
   Google Scholar
• Abu-Huwaij R, Al-Assaf SF, Hamed R. 2022. Recent exploration of nanoemulsions for drugs and cosmeceuticals delivery. J Cosmet Dermatol. 21(9):3729–3740. doi: 10.1111/jocd.14704.
   PubMed Web of Science ®Google Scholar
• Ahmed S, Kassem MA, Sayed S. 2020. Bilosomes as promising nanovesicular carriers for improved transdermal delivery: construction, in vitro optimization, ex vivo permeation and in vivo evaluation. Int J Nanomedicine. 15:9783–9798. PMID: 33324052; PMCID: PMC7733410. doi: 10.2147/IJN.S278688.
   PubMed Web of Science ®Google Scholar
• Agirre M, Zarate J, Puras G, Ojeda E, Pedraz JL. 2015. Improving transfection efficiency of ultrapure oligochitosan/DNA polyplexes by medium acidification. Drug Deliv. 22(1):100–110. doi: 10.3109/10717544.2013.871373.
   PubMed Web of Science ®Google Scholar
• Ag Seleci D, Seleci M, Walter J-G, Stahl F, Scheper T. 2016. Niosomes as nanoparticular drug carriers: fundamentals and recent applications. J Nanomater. 2016:1–13. doi: 10.1155/2016/7372306.
   Web of Science ®Google Scholar
• Ag Seleci D, Maurer V, Stahl F, Scheper T, Garnweitner G. 2019. Rapid microfluidic preparation of niosomes for targeted drug delivery. IJMS. 20(19):4696. doi: 10.3390/ijms20194696.
   Google Scholar
• Akbari J, Saeedi M, Zangabad PS, Rahimzadeh P, Kouhi M, Akhtari J, Karimi M. 2019. Niosomes as a modern and promising drug delivery system: recent patents and emerging drugs. Recent Pat Drug Deliv Formul. 13(3):188–200.
   Google Scholar
• Alagawany M, Abd El-Hack ME, Farag MR, Gopi M, Karthik K, Malik YS, Dhama K. 2017. Rosmarinic acid: modes of action, medicinal values and health benefits. Anim Health Res Rev. 18(2):167–176. doi: 10.1017/S1466252317000081.
   PubMed Web of Science ®Google Scholar
• Alam MA, Al-Jenoobi FI, Al-Mohizea AM, Ali R. 2019. Niosomes as a potential carrier for topical delivery of bioactives for management of skin disorders. Curr Pharm Des. 25(17):1916–1930.
   Google Scholar
• Alhassan A, Ali M, Tariq M, Ali M, Khalid N. 2017. Niosomes: a review of preparation, characterization, and applications. Drug Dev Ind Pharm. 43(9):1514–1530.
   Google Scholar
• Ali M, Alhassan A, Tariq M, Ali M, Khalid N. 2017. Niosomes: a promising drug delivery system. Drug Deliv. 24(1):14–26.
   Web of Science ®Google Scholar
• Aljuffali IA, Lin C-H, Yang S-C, Alalaiwe A, Fang J-Y. 2022. Nanoencapsulation of tea catechins for enhancing skin absorption and therapeutic efficacy. AAPS PharmSciTech. 23(6):187. doi: 10.1208/s12249-022-02344-3.
   PubMed Web of Science ®Google Scholar
• Alqahtani MA. 2017. Niosomes as novel drug delivery system: a review. Int J Pharm Sci Res. 8(6):2320–2330.
   Google Scholar
• Al-Mahallawi AM, Abdelbary AA, Aburahma MH. 2015. Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam. Int J Pharm. 485(1–2):329–340. doi: 10.1016/j.ijpharm.2015.03.033.
   PubMed Web of Science ®Google Scholar
• Aparajay P, Dev A. 2022. Functionalized niosomes as a smart delivery device in cancer and fungal infection. Eur J Pharm Sci. 168:106052. doi: 10.1016/j.ejps.2021.106052.
   PubMed Web of Science ®Google Scholar
• Arafa MG, Ghalwash D, El-Kersh DM, Elmazar MM. 2018. Propolis-based niosomes as oromuco-adhesive films: a randomized clinical trial of a therapeutic drug delivery platform for the treatment of oral recurrent aphthous ulcers. Sci Rep. 8(1):18056. doi: 10.1038/s41598-018-37157-7.
   PubMedGoogle Scholar
• Bhavani GD, Lakshmi PV. 2020. Recent advances of non-ionic surfactant-based nano-vesicles (niosomes and proniosomes): a brief review of these in enhancing transdermal delivery of drug. Futur J Pharm Sci. 6(1):100. doi: 10.1186/s43094-020-00117-y.
   Web of Science ®Google Scholar
• Balakrishnan P, Shanmugam S, Lee WS, Lee WM, Kim JO, Oh DH, Kim DD, Kim JS, Yoo BK, Choi HG, et al. 2009. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery. Int J Pharm. 377(1–2):1–8. doi: 10.1016/j.ijpharm.2009.04.020.
   PubMed Web of Science ®Google Scholar
• Bartelds R, Nematollahi MH, Pols T, Stuart MCA, Pardakhty A, Asadikaram G, Poolman B. 2018. Niosomes, an alternative for liposomal delivery. PLOS One. 13(4):e0194179. doi: 10.1371/journal.pone.0194179.
   PubMed Web of Science ®Google Scholar
• Bhardwaj P, Tripathi P, Gupta R, Pandey S. 2020. Niosomes: a review on niosomal research in the last decade. J Drug Delivery Sci Technol. 56(Part A):101581. doi: 10.1016/j.jddst.2020.101581.
   Google Scholar
• Budhiraja A, Dhingra G. 2015. Development and characterization of a novel antiacne niosomal gel of rosmarinic acid. Drug Deliv. 22(6):723–730. doi: 10.3109/10717544.2014.903010.
   PubMed Web of Science ®Google Scholar
• Carballo-Pedrares N, Kattar A, Concheiro A, Alvarez-Lorenzo C, Rey-Rico A. 2021. Niosomes-based gene delivery systems for effective transfection of human mesenchymal stem cells. Mater Sci Eng C Mater Biol Appl. 128:112307. doi: 10.1016/j.msec.2021.112307.
   PubMed Web of Science ®Google Scholar
• Chauhan MK, Sahoo PK, Rawat AS, Singh A, Bamrara A, Sharma D. 2015. Bilosomes: A novel approach to meet the challenges in oral immunization. Recent Pat Drug Deliv Formul. 9(3):201–212. doi: 10.2174/1872211309666150615111803.
   PubMedGoogle Scholar
• Chen RP, Chavda VP, Patel AB, Chen ZS. 2022. Phytochemical delivery through transfersome (Phytosome): an advanced transdermal drug delivery for complementary medicines. Front Pharmacol. 13:850862. doi: 10.3389/fphar.2022.850862.
   PubMed Web of Science ®Google Scholar
• Chen S, Hanning S, Falconer J, Locke M, Wen J. 2019. Recent advances in non-ionic surfactant vesicles (niosomes): fabrication, characterization, pharmaceutical and cosmetic applications. Eur J Pharm Biopharm. 144:18–39. doi: 10.1016/j.ejpb.2019.08.015.
   PubMed Web of Science ®Google Scholar
• Cheng R, Xu T, Wang C, Gan C. 2021. The stabilization and antioxidant performances of coenzyme Q10-loaded niosomes coated by PEG and chitosan. J Mol Liq. 325:115194. doi: 10.1016/j.molliq.2020.115194.
   Web of Science ®Google Scholar
• Choi MH, Yang SH, Kim DS, Kim ND, Shin HJ, Liu K. 2021. Novel quercetin derivative of 3,7-dioleylquercetin shows less toxicity and highly potent tyrosinase inhibition activity. IJMS. 22(8):4264. doi: 10.3390/ijms22084264.
   Google Scholar
• Danhui Li, Nataly Martini, Mengyang Liu, James R. Falconer, Michelle Locke, Zimei Wu, Jingyuan Wen. 2021. Non-ionic surfactant vesicles as a carrier system for dermal delivery of (+)-Catechin and their antioxidant effects. J Drug Target. 29(3):310–322. doi: 10.1080/1061186X.2020.1835923.
   PubMed Web of Science ®Google Scholar
• Durak S, Esmaeili Rad M, Alp Yetisgin A, Eda Sutova H, Kutlu O, Cetinel S, Zarrabi A. 2020. Niosomal drug delivery systems for ocular disease-recent advances and future prospects. Nanomaterials . 10(6):1191. doi: 10.3390/nano10061191.
   Web of Science ®Google Scholar
• El-Malah Y, Elnaggar YS, El-Refaie WM. 2017. A promising approach to improve skin penetration and retard inflammation: niosomal gel of piroxicam. Artif Cells Nanomed Biotechnol. 45(4):729–737.
   Google Scholar
• Ertekin ZC, Bayindir ZS, Yuksel N. 2015. Stability studies on piroxicam encapsulated niosomes. Curr Drug Deliv. 12(2):192–199. doi: 10.2174/1567201811666140723115852.
   PubMed Web of Science ®Google Scholar
• Falconer RJ. 2016. Applications of isothermal titration calorimetry—the research and technical developments from 2011 to 2015. J Mol Recognit. 29(10):504–515. doi: 10.1002/jmr.2550.
   PubMed Web of Science ®Google Scholar
• Gallego I, Villate-Beitia I, Martínez-Navarrete G, Menéndez M, López-Méndez T, Soto-Sánchez C, Zárate J, Puras G, Fernández E, Pedraz JL. 2019. Non-viral vectors based on cationic niosomes and minicircle DNA technology enhance gene delivery efficiency for biomedical applications in retinal disorders. Nanomedicine. 17:308–318. doi: 10.1016/j.nano.2018.12.018.
   PubMed Web of Science ®Google Scholar
• Ge X, Wei M, He S, Yuan W-E. 2019. Advances of non-ionic surfactant vesicles (Niosomes) and their application in drug delivery. Pharmaceutics. 11(2):55. doi: 10.3390/pharmaceutics11020055.
   PubMed Web of Science ®Google Scholar
• Gharbavi M, Amani J, Kheiri-Manjili H, Danafar H, Sharafi A. 2018. Niosome: a promising nanocarrier for natural drug delivery through blood-brain barrier. Adv Pharmacol Sci. 2018:6847971. doi: 10.1155/2018/6847971.
   PubMed Web of Science ®Google Scholar
• Ghasemiyeh P, Mohammadi-Samani S. 2020. Potential of nanoparticles as permeation enhancers and targeted delivery options for skin: advantages and disadvantages. Drug Des Devel Ther. 14:3271–3289. doi: 10.2147/DDDT.S264648.
   PubMed Web of Science ®Google Scholar
• Gogoi P, Gogoi M. 2020. Niosomal drug delivery system: a promising approach for skin drug delivery. JDrug DelivTher. 10(5):120–127.
   Google Scholar
• Grijalvo S, Puras G, Zárate J, Sainz-Ramos M, Qtaish NAL, López T, Mashal M, Attia N, Díaz D, Pons R, et al. 2019. Cationic niosomes as non-viral vehicles for nucleic acids: challenges and opportunities in gene delivery. Pharmaceutics. 11(2):50. doi: 10.3390/pharmaceutics11020050.
   PubMed Web of Science ®Google Scholar
• Hajhashemi V, Rajabi P, Mardani M. 2019. Beneficial effects of pumpkin seed oil as a topical hair growth promoting agent in a mice model. Avicenna J Phytomed. 9(6):499–504. doi: 10.22038/AJP.2019.13463.
   PubMed Web of Science ®Google Scholar
• Hamimed S, Jabberi M, Chatti A. 2022. Nanotechnology in drug and gene delivery. Naunyn Schmiedebergs Arch Pharmacol. 395(7):769–787. Jul doi: 10.1007/s00210-022-02245-z.
   PubMed Web of Science ®Google Scholar
• Hasan AA, Madkor H, Wageh S. 2013. Formulation and evaluation of metformin hydrochloride-loaded niosomes as controlled release drug delivery system. Drug Delivery. 20(3–4):120–126. doi: 10.3109/10717544.2013.779332.
   PubMed Web of Science ®Google Scholar
• Ho CH, Sood T, Zito PM. 2022. Androgenetic Alopecia. Treasure Island. StatPearls Publishing LLC; https://www.ncbi.nlm.nih.gov/books/NBK430924/.
   Google Scholar
• Huang L, Teng W, Cao J, Wang J. 2022. Liposomes as delivery system for applications in meat products. Foods. 11(19):3017. doi: 10.3390/foods11193017.
   PubMed Web of Science ®Google Scholar
• Islam MA, Firdous J, Choi YJ, Yun CH, Cho CS. 2014. Regulation of endocytosis by non-viral vectors for efficient gene activity. J Biomed Nanotechnol. 10(1):67–80. doi: 10.1166/jbn.2014.1682.
   PubMed Web of Science ®Google Scholar
• Jain AK, et al. 2013. Bilosomes: a novel approach to the targeted delivery of drugs and vaccines. J Drug Targeting. 21(10):911–922.
   Web of Science ®Google Scholar
• Jeong WY, Kwon M, Choi HE, Kim KS. 2021. Recent advances in transdermal drug delivery systems: a review. Biomater Res. 25(1):24. doi: 10.1186/s40824-021-00226-6.
   PubMedGoogle Scholar
• Jiang X, Zhao H, Li W. 2022. Microneedle-mediated transdermal delivery of drug-carrying nanoparticles. Front Bioeng Biotechnol. 10:840395. doi: 10.3389/fbioe.2022.840395.
   PubMed Web of Science ®Google Scholar
• Jigar V, Puja V, Dhaval R, Paresh P. 2011. Development of topical niosomal gel of benzoyl peroxide. Int Sch Res Notices. 2011(6):1–6. doi: 10.5402/2011/503158.
   Google Scholar
• Joseph MA, Nikolai AS, Stephen MM. 2020. The applied anatomy of human skin: a model for regeneration. Wound Med. 28:100179. doi: 10.1016/j.wndm.2020.100179.
   Google Scholar
• Joy C, Nair SK, Krishna Kumar K, Dineshkumar B. 2021. Niosomes as nano-carrier based targeted drug delivery system. J Drug Delivery Ther. 11(4-S):166–170. doi: 10.22270/jddt.v11i4-S.4907.
   Google Scholar
• Junyaprasert VB, Teeranachaideekul V, Supaperm T. 2008. Effect of charged and non-ionic membrane additives on physicochemical properties and stability of niosomes. AAPS PharmSciTech. 9(3):851–859. doi: 10.1208/s12249-008-9121-1.
   PubMed Web of Science ®Google Scholar
• Kar M, Saquib M, Jain DK. 2020. Formulation development and evaluation of aspasomes containing skin whitening agent. Manipal J Pharm Sci 6(1): 47–53, article 8. https://impressions.manipal.edu/mjps/vol6/iss1/8.
   Google Scholar
• Karimi M, Sahandi Zangabad P, Baghaee-Ravari S, Ghazadeh M, Mirshekari H, Hamblin MR. 2017. Smart nanostructures for cargo delivery: uncaging and activating by light. J Am Chem Soc. 139(13):4584–4610. doi: 10.1021/jacs.6b08313.
   PubMed Web of Science ®Google Scholar
• Kaul S, Gulati N, Verma D, Mukherjee S, Nagaich U. 2018. Role of nanotechnology in cosmeceuticals: a review of recent advances. J Pharm. 2018:3420204. doi: 10.1155/2018/3420204.
   Google Scholar
• Kauslya A, Borawake PD, Shinde JV, Chavan RS. 2021. Niosomes: a novel carrier drug delivery system. J Drug Delivery Ther. 11(1):162–170. doi: 10.22270/jddt.v11i1.4479.
   Google Scholar
• Keck CM, Müller RH. 2013. Nanotoxicological classification system (NCS) - a guide for the risk-benefit assessment of nanoparticulate drug delivery systems. Eur J Pharm Biopharm. 84(3):445–448. doi: 10.1016/j.ejpb.2013.01.001.
   PubMed Web of Science ®Google Scholar
• Leung AWY, Amador C, Wang LC, Mody UV, Bally MB. 2019. What drives innovation: the Canadian touch on liposomal therapeutics. Pharmaceutics. 11(3):124. doi: 10.3390/pharmaceutics11030124.
   PubMed Web of Science ®Google Scholar
• Limongi T, Susa F, Marini M, Allione M, Torre B, Pisano R, di Fabrizio E. 2021. Lipid-based nanovesicular drug delivery systems. Nanomaterials. 11(12):3391. doi: 10.3390/nano11123391.
   Web of Science ®Google Scholar
• Li J, Xiang H, Zhang Q, Miao X. 2022. Polysaccharide-based transdermal drug delivery. Pharmaceuticals. 15(5):602. doi: 10.3390/ph15050602.
   Web of Science ®Google Scholar
• Li Z, Fang X, Yu D. 2021. Transdermal drug delivery systems and their use in obesity treatment. IJMS. 22(23):12754. doi: 10.3390/ijms222312754.
   Google Scholar
• Lu B, Huang Y, Chen Z, Ye J, Xu H, Chen W, Long X. 2019. Niosomal nanocarriers for enhanced skin delivery of quercetin with functions of anti-tyrosinase and antioxidant. Molecules. 24(12):2322. doi: 10.3390/molecules24122322.
   PubMed Web of Science ®Google Scholar
• Mahmoud K, Mohamed M, Amr I, Dina L. 2018. An overview on niosomes: a drug nanocarrier. Drug Des Int Prop Int J. 1(5):143–151. DDIPIJ. MS.ID.000125.
   Google Scholar
• Mali N, Darandale S, Vavia P. 2013. Niosomes as a vesicular carrier for topical administration of minoxidil: formulation and in vitro assessment. Drug Deliv Transl Res. 3(6):587–592. doi: 10.1007/s13346-012-0083-1.
   PubMed Web of Science ®Google Scholar
• Manconi M, Sinico C, Valenti D, Lai F, Fadda AM. 2006. Niosomes as carriers for tretinoin. III. a study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin. Int J Pharm. 311(1–2):11–19. doi: 10.1016/j.ijpharm.2005.11.045.
   PubMed Web of Science ®Google Scholar
• Manosroi A, Jantrawut P, Manosroi J. 2008. Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium. Int J Pharm. 360(1–2):156–163. doi: 10.1016/j.ijpharm.2008.04.033.
   PubMed Web of Science ®Google Scholar
• Marianecci C, Di Marzio L, Rinaldi F, Celia C, Paolino D, Alhaique F, Esposito S, Carafa M. 2014. Niosomes from 80s to present: the state of the art. Adv Colloid Interface Sci. 205:187–206. doi: 10.1016/j.cis.2013.11.018.
   PubMed Web of Science ®Google Scholar
• Mawazi SM, Ann TJ, Widodo RT. 2022. Application of niosomes in cosmetics: a systematic review. Cosmetics. 9(6):127. doi: 10.3390/cosmetics9060127.
   Google Scholar
• McLaughlin J, Watterson S, Layton AM, Bjourson AJ, Barnard E, McDowell A. 2019. Propionibacterium acnes and acne vulgaris: new Insights from the integration of population genetic, multi-omic, biochemical and host-microbe studies. Microorganisms. 7(5):128. doi: 10.3390/microorganisms7050128.
   PubMed Web of Science ®Google Scholar
• Mehrarya M, Gharehchelou B, Haghighi Poodeh S, Jamshidifar E, Karimifard S, Farasati Far B, Akbarzadeh I, Seifalian A. 2022. Niosomal formulation for antibacterial applications. J Drug Target. 30(5):476–493. doi: 10.1080/1061186X.2022.2032094.
   PubMed Web of Science ®Google Scholar
• Miyazawa T, Itaya M, Burdeos GC, Nakagawa K, Miyazawa T. 2021. a critical review of the use of surfactant-coated nanoparticles in nanomedicine and food nanotechnology. Int J Nanomedicine. 16:3937–3999. doi: 10.2147/IJN.S298606.
   PubMed Web of Science ®Google Scholar
• Moghassemi S, Hadjizadeh A. 2014. Nano-niosomes as nanoscale drug delivery systems: an illustrated review. J Control Release. 185:22–36. doi: 10.1016/j.jconrel.2014.04.015.
   PubMed Web of Science ®Google Scholar
• Mohamadi N, Soltanian S, Raeiszadeh M, Moeinzadeh M, Ohadi M, Sharifi F, Pardakhty A, Sharififar F. 2022. Characteristics and in vitro anti skin aging activity and UV radiation protection of morin loaded in niosomes. J Cosmet Dermatol. 21(11):6326–6335. doi: 10.1111/jocd.15273.
   PubMed Web of Science ®Google Scholar
• Mohammadi S, Pardakhty A, Khalili M, Fathi R, Rezaeizadeh M, Farajzadeh S, Mohebbi A, Aflatoonian M. 2019. Niosomal benzoyl peroxide and clindamycin lotion versus niosomal clindamycin lotion in treatment of acne vulgaris: a randomized clinical trial. Adv Pharm Bull. 9(4):578–583. doi: 10.15171/apb.2019.066.
   PubMed Web of Science ®Google Scholar
• Mohsen AM, AbouSamra MM, ElShebiney SA. 2017. Enhanced oral bioavailability and sustained delivery of glimepiride via niosomal encapsulation: in-vitro characterization and in-vivo evaluation. Drug Dev Ind Pharm. 43(8):1254–1264. doi: 10.1080/03639045.2017.1310224.
   PubMed Web of Science ®Google Scholar
• Momekova DB, Gugleva VE, Petrov PD. 2021. Nanoarchitectonics of multifunctional niosomes for advanced drug delivery. ACS Omega. 6(49):33265–33273. doi: 10.1021/acsomega.1c05083.
   PubMed Web of Science ®Google Scholar
• Muzzalupo R, Tavano L. 2015. Niosomal drug delivery for transdermal targeting: recent advances. RRTD. 4:23–33. doi: 10.2147/RRTD.S64773.
   Google Scholar
• Muzzalupo R, Mazzotta E. 2019. Do niosomes have a place in the field of drug delivery? Expert Opin Drug Deliv. 16(11):1145–1147. doi: 10.1080/17425247.2019.1663821.
   PubMed Web of Science ®Google Scholar
• Nasseri B. 2005. Effect of cholesterol and temperature on the elastic properties of niosomal membranes. Int J Pharm. 300(1–2):95–101. doi: 10.1016/j.ijpharm.2005.05.009.
   PubMed Web of Science ®Google Scholar
• Nowroozi F, Almasi A, Javidi J, Haeri A, Dadashzadeh S. 2018. Effect of surfactant type, cholesterol content and various downsizing methods on the particle size of niosomes. Iran J Pharm Res. 17(Suppl2):1–11.
   PubMed Web of Science ®Google Scholar
• Nsairat H, Khater D, Sayed U, Odeh F, Al Bawab A, Alshaer W. 2022. Liposomes: structure, composition, types, and clinical applications. Heliyon. 8(5):e09394. doi: 10.1016/j.heliyon.2022.e09394.
   PubMed Web of Science ®Google Scholar
• Obeid M, Khadra I, Aljabali A, Amawi H, Ferro V. 2022. Characterisation of niosome nanoparticles prepared by microfluidic mixing for drug delivery. Int J Pharm X. 4:100137. doi: 10.1016/j.ijpx.2022.100137.
   PubMedGoogle Scholar
• Ojeda E, Agirre M, Villate-Beitia I, Mashal M, Puras G, Zarate J, Pedraz JL. 2016a. Elaboration and physicochemical characterization of niosome-based nioplexes for gene delivery purposes. Methods Mol Biol. 1445:63–75.
   PubMedGoogle Scholar
• Ojeda E, Puras G, Agirre M, Zarate J, Grijalvo S, Eritja R, DiGiacomo L, Caracciolo G, Pedraz JL. 2016b. The role of helper lipids in the intracellular disposition and transfection efficiency of niosome formulations for gene delivery to retinal pigment epithelial cells. Int J Pharm. 503(1–2):115–126. doi: 10.1016/j.ijpharm.2016.02.043.
   PubMedGoogle Scholar
• Ojeda E, Puras G, Agirre M, Zárate J, Grijalvo S, Pons R, Eritja R, Martinez-Navarrete G, Soto-Sanchez C, Fernández E, et al. 2015. Niosomes based on synthetic cationic lipids for gene delivery: the Influence of polar head-groups on the transfection efficiency in HEK-293, ARPE-19 and MSC-D1 cells. Org Biomol Chem. 13(4):1068–1081. doi: 10.1039/c4ob02087a.
   PubMed Web of Science ®Google Scholar
• O'Leary EI, Jiang Z, Strub MP, Lee JC. 2018. Effects of phosphatidylcholine membrane fluidity on the conformation and aggregation of N-terminally acetylated α-synuclein. J Biol Chem. 293(28):11195–11205. doi: 10.1074/jbc.RA118.002780.
   PubMed Web of Science ®Google Scholar
• Oswald M, Platscher M, Geissler S, Goepferich A. 2016. HPLC analysis as a tool for assessing targeted liposome composition. Int J Pharm. 497(1–2):293–300. doi: 10.1016/j.ijpharm.2015.11.014.
   PubMedGoogle Scholar
• Opatha SAT, Titapiwatanakun V, Chutoprapat R. 2020. Transfersomes: a promising nanoencapsulation technique for transdermal drug delivery. Pharmaceutics. 12(9):855. doi: 10.3390/pharmaceutics12090855.
   PubMed Web of Science ®Google Scholar
• Paluszkiewicz P, Martuszewski A, Zaręba N, Wala K, Banasik M, Kepinska M. 2021. The application of nanoparticles in diagnosis and treatment of kidney diseases. IJMS. 23(1):131. doi: 10.3390/ijms23010131.
   Google Scholar
• Pandey M, Choudhury H, Gorain B, Tiong SQ, Wong GYS, Chan KX, They X, Chieu WS. 2021. Site-specific vesicular drug delivery system for skin cancer: a novel approach for targeting. Gels. 7(4):218. doi: 10.3390/gels7040218.
   PubMed Web of Science ®Google Scholar
• Pandey R, Bhairam M, Shukla SS, Gidwani B. 2021. Colloidal and vesicular delivery system for herbal bioactive constituents. Daru. 29(2):415–438. doi: 10.1007/s40199-021-00403-x.
   PubMed Web of Science ®Google Scholar
• Patil S, Sandberg A, Heckert E, Self W, Seal S. 2007. Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential. Biomaterials. 28(31):4600–4607. doi: 10.1016/j.biomaterials.2007.07.029.
   PubMed Web of Science ®Google Scholar
• Perez Ruiz de Garibay A. 2016. Endocytosis in gene therapy with non-viral vectors. Wien Med Wochenschr. 166(7–8):227–235. doi: 10.1007/s10354-016-0450-5.
   PubMedGoogle Scholar
• Puras G, Martínez-Navarrete G, Mashal M, Zárate J, Agirre M, Ojeda E, Grijalvo S, Eritja R, Diaz-Tahoces A, Avilés-Trigueros M, et al. 2015. Protamine/DNA/Niosome ternary nonviral vectors for gene delivery to the retina: the role of protamine. Mol Pharm. 12(10):3658–3671. doi: 10.1021/acs.molpharmaceut.5b00422.
   PubMed Web of Science ®Google Scholar
• Puras G, Mashal M, Zárate J, Agirre M, Ojeda E, Grijalvo S, Eritja R, Diaz-Tahoces A, Martínez Navarrete G, Avilés-Trigueros M, et al. 2014. A novel cationic niosome formulation for gene delivery to the retina. J Control Release. 174:27–36. doi: 10.1016/j.jconrel.2013.11.004.
   PubMed Web of Science ®Google Scholar
• Puras G, Zarate J, Diaz-Tahoces A, Aviles-Trigueros M, Fernandez E, Pedraz JL. 2013. Oligochitosan polyplexes as carriers for retinal gene delivery. Eur J Pharm Sci. 48(1–2):323–331. doi: 10.1016/j.ejps.2012.11.009.
   PubMed Web of Science ®Google Scholar
• Qu F, Geng R, Liu Y, Zhu J. 2022. Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment. Theranostics. 12(7):3372–3406. doi: 10.7150/thno.69999.
   PubMed Web of Science ®Google Scholar
• Radmard A, Saeedi M, Morteza-Semnani K, Hashemi SMH, Nokhodchi A. 2021. An eco-friendly and green formulation in lipid nanotechnology for delivery of a hydrophilic agent to the skin in the treatment and management of hyperpigmentation complaints: arbutin noisome (Arbusome). Colloids Surf B Biointerfaces. 201:111616. doi: 10.1016/j.colsurfb.2021.111616.
   PubMed Web of Science ®Google Scholar
• Ramadon D, McCrudden MTC, Courtenay AJ, Donnelly RF. 2022. Enhancement strategies for transdermal drug delivery systems: current trends and applications. Drug Deliv Transl Res. 12(4):758–791. doi: 10.1007/s13346-021-00909-6.
   PubMed Web of Science ®Google Scholar
• Salvioni L, Morelli L, Ochoa E, Labra M, Fiandra L, Palugan L, Prosperi D, Colombo M. 2021. The emerging role of nanotechnology in skin care. Adv Colloid Interface Sci. 293:102437. doi: 10.1016/j.cis.2021.102437.
   PubMed Web of Science ®Google Scholar
• Khoee S, Yaghoobian M. 2017. Chapter 6 - Niosomes: a novel approach in modern drug delivery systems, editor(s): Ecaterina Andronescu, Alexandru Mihai Grumezescu, in micro and nano technologies, nanostructures for drug delivery, Elsevier; p. 207-237. ISBN 9780323461436 doi: 10.1016/B978-0-323-46143-6.00006-3.
   Google Scholar
• Shah VM, Nguyen DX, Patel P, Cote B, Al-Fatease A, Pham Y, Huynh MG, Woo Y, Alani AW. 2019. Liposomes produced by microfluidics and extrusion: a comparison for scale-up purposes. Nanomedicine. 18:146–156. doi: 10.1016/j.nano.2019.02.019.
   PubMed Web of Science ®Google Scholar
• Sharma D, Ali AAE, Aate JR. 2018. Niosomes as novel drug delivery system: review article. PT. 6(3):58–65. doi: 10.29161/PT.v6.i3.2018.58.
   Google Scholar
• Sharma A, Kuhad A, Bhandari R. 2022a. Novel nanotechnological approaches for treatment of skin-aging. J Tissue Viability. 31(3):374–386. doi: 10.1016/j.jtv.2022.04.010.
   PubMed Web of Science ®Google Scholar
• Sharma R, Dua JS, Parsad DN. 2022b. An overview on niosomes: novel pharmaceutical drug delivery system. J Drug Delivery Ther. 12(2-s):171–177. doi: 10.22270/jddt.v12i2-S.5264.
   Google Scholar
• Shatalebi MA, Mostafavi SA, Moghaddas A. 2010. Niosome as a drug carrier for topical delivery of N-acetyl glucosamine. Res Pharm Sci. 5(2):107–117.
   PubMedGoogle Scholar
• Slocum M, Garcia SF, McKoy JM. 2019. Cancer drug toxicity: moving from patient to Survivor. In: McKoy, J., West, D. editors. Cancer policy: pharmaceutical safety. cancer treatment and research, vol 171. Cham: Springer; p. 107–118. doi: 10.1007/978-3-319-43896-2_8.
   Google Scholar
• Sultana N, Ahmed M. 2021. Niosomes: an innovative drug delivery system. J Controlled Release. 330:205–216.
   Google Scholar
• Tan Y, Li X, Zhang L, Chen L. 2021. Niosomes as promising drug delivery systems for topical and transdermal administration. J Drug Deliv Sci Technol. 63:102371.
   Google Scholar
• Teeranachaideekul V, Parichatikanond W, Junyaprasert VB, Morakul B. 2022. Pumpkin seed oil-loaded niosomes for topical application: 5α-reductase inhibitory, anti-inflammatory, and in vivo anti-hair loss effects. Pharmaceuticals. 15(8):930. doi: 10.3390/ph15080930.
   Web of Science ®Google Scholar
• Toncic RJ, Jakasa I, Hadzavdic SL, Goorden SM, Vlugt KJG, Stet FS, Balic A, Petkovic M, Pavicic B, Zuzul K, et al. 2020. Altered Levels of Sphingosine, Sphinganine and their ceramides in atopic dermatitis are related to skin barrier function, disease severity and local cytokine Milieu. IJMS. 21(6):1958. PMID: 32183011; PMCID: PMC7139865. doi: 10.3390/ijms21061958.
   Google Scholar
• Tristram-Nagle S, Nagle JF. 2004. Lipid bilayers: thermodynamics, structure, fluctuations, and interactions. Chem Phys Lipids. 127(1):3–14. doi: 10.1016/j.chemphyslip.2003.09.002.
   PubMed Web of Science ®Google Scholar
• Villate-Beitia I, Gallego I, Martínez-Navarrete G, Zárate J, López-Méndez T, Soto-Sánchez C, Santos-Vizcaíno E, Puras G, Fernández E, Pedraz JL. 2018. Polysorbate 20 non-ionic surfactant enhances retinal gene delivery efficiency of cationic niosomes after intravitreal and subretinal administration. Int J Pharm. 550(1–2):388–397. doi: 10.1016/j.ijpharm.2018.07.035.
   PubMedGoogle Scholar
• Wen H, Jung H, Li X. 2015. Drug delivery approaches in addressing clinical pharmacology-related issues: opportunities and challenges. Aaps J. 17(6):1327–1340. doi: 10.1208/s12248-015-9814-9.
   PubMed Web of Science ®Google Scholar
• Yasamineh S, Yasamineh P, Kalajahi HG, Gholizadeh O, Yekanipour Z, Afkhami H, Eslami M, Kheirkhah AH, Taghizadeh M, Yazdani Y, et al. 2022. A state-of-the-art review on the recent advances of niosomes as a targeted drug delivery system. Int J Pharm. 624:121878. doi: 10.1016/j.ijpharm.2022.121878.
   PubMed Web of Science ®Google Scholar
• Yeo PL, Lim CL, Chye SM, Anna L, Koh YK. 2018. Niosomes: a review of their structure, properties, methods of preparation, and medical applications. Asian Biomedicine. 11(4):301–314. doi: 10.1515/abm-2018-0002.
   Web of Science ®Google Scholar
• Zaid Alkilani A, Abu-Zour H, Alshishani A, Abu-Huwaij R, Basheer HA, Abo-Zour H. 2022. Formulation and evaluation of niosomal alendronate sodium encapsulated in polymeric microneedles: in vitro studies, stability study and cytotoxicity study. Nanomaterials. 12(20):3570. PMID: 36296760; PMCID: PMC9611853. doi: 10.3390/nano12203570.
   Web of Science ®Google Scholar
• Zarei A. 2020. Niosomes as novel drug delivery systems: potential applications and toxicity evaluations. J Biomed Sci. 27(1):39.
   PubMedGoogle Scholar